Mitigating Inappropriate Prescribing in Multimorbid Geriatric Inpatients: The 2023 AGS Beers Criteria Protocol
Systematic deprescribing framework for high-risk anticholinergics, sedatives, and renal-dependent pharmacotherapy in older adults.
The American Geriatrics Society (AGS) Beers Criteria provides explicit, evidence-based recommendations on potentially inappropriate medications (PIMs) in older adults (aged >= 65 years). Inappropriate pharmacotherapy in seniors precipitates drug-induced cognitive decline, delirium, motor vehicle collisions, falls with hip fractures, and avoidable emergency department admissions through anticholinergic burden and altered pharmacokinetics.
Essential Clinical Findings
- Inpatients prescribed >= 1 Beers Criteria medication have a 2.4-fold higher risk of adverse drug events (ADEs) during hospitalization.
- First-generation antihistamines (diphenhydramine, hydroxyzine) carry severe anticholinergic toxicity, inducing acute delirium and urinary retention in elderly patients.
- Concurrent prescription of >= 3 central nervous system (CNS)-active agents increases fall and hip fracture rates by 300%.
- Sliding-scale regular insulin without basal background insulin causes severe hypoglycemic episodes without improving glycemic control.
High-Alert Beers Criteria Drug Classes & Safer Clinical Alternatives
| Medication / Class | Primary Clinical Risk in Older Adults | Recommended Safer Alternative |
|---|---|---|
| First-Gen Antihistamines (Diphenhydramine, Hydroxyzine) | High anticholinergic burden: confusion, acute delirium, dry mouth, urinary retention | Second-gen non-sedating antihistamines (Cetirizine, Loratadine, Fexofenadine) |
| Benzodiazepines & Z-drugs (Lorazepam, Zolpidem, Eszopiclone) | Increased sensitivity; ataxia, cognitive impairment, delirium, motor vehicle crashes, hip fractures | Cognitive Behavioral Therapy for Insomnia (CBT-I); low-dose Melatonin (0.5-3 mg) |
| Non-selective NSAIDs (Indomethacin, Ketorolac, Naproxen) | High risk of gastrointestinal bleeding, acute renal failure, hypertension exacerbation, heart failure decompensation | Acetaminophen (max 2-3 g/day); topical NSAIDs (Diclofenac gel 1%) |
| Sliding-Scale Regular Insulin Monotherapy | Extreme risk of iatrogenic hypoglycemia without improving glycemic stability | Basal-bolus insulin regimens titrated to individual functional goals (HbA1c 7.5-8.0%) |
| Tricyclic Antidepressants (Amitriptyline, Imipramine) | Highly anticholinergic, orthostatic hypotension, cardiac conduction delays, lethal in overdose | SSRIs (Sertraline, Escitalopram) or SNRIs (Duloxetine for neuropathic pain) |
Step-by-Step Clinical Decision Algorithm
Comprehensive Medication Reconciliation at Admission
Catalogue all prescription, over-the-counter, and herbal supplements; calculate baseline creatinine clearance using Cockcroft-Gault.
Screen for Beers Criteria PIMs
Evaluate active orders against Beers Tables: medications to avoid, medications to avoid with specific diseases, and drugs to use with caution.
Calculate Cumulative Anticholinergic Cognitive Burden (ACB)
Sum anticholinergic scores; if score >= 3, systematically identify candidates for deprescribing.
Stepwise Deprescribing Protocol
Taper addictive or withdrawal-prone agents (benzodiazepines, PPIs, opioids) slowly over 4 to 12 weeks with patient education.
Clinical Pitfalls & High-Alert Warnings
- •Prescribing anticholinergic antispasmodics (oxybutynin) for urinary urge incontinence in patients already suffering from early cognitive impairment.
- •Treating adverse drug effects with additional medications (prescribing cascade), such as treating amlodipine-induced peripheral edema with furosemide.
- •Relying on standard serum creatinine alone to assess renal function in sarcopenic elderly patients.
Related Point-of-Care Calculation Engines
Frequently Asked Clinical Questions
Are there exceptions where Beers Criteria medications can be justified in older adults?
Yes. Beers Criteria recommendations are guidelines rather than absolute contraindications. In palliative care, end-stage malignancy, or treatment-refractory conditions, medications such as benzodiazepines, tricyclic antidepressants, or strong opioids are clinically indicated under close physician monitoring.
How should proton pump inhibitors (PPIs) be managed in the elderly?
The 2023 Beers Criteria advises avoiding PPI use beyond 8 weeks without a compelling indication (severe esophagitis, Barrett esophagus, chronic NSAID therapy) due to elevated risks of Clostridioides difficile infection, bone fractures, hypomagnesemia, and acute interstitial nephritis.
Primary Peer-Reviewed Citations & Evidence
- 1.By the 2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023.doi:10.1111/jgs.18372[PMID: 37139824]
- 2.O’Mahony D, Cherubini A, Guiteras AR, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023.doi:10.1007/s41999-023-00777-y[PMID: 37188989]
Clinical Decision Support Notice: This protocol is engineered strictly for licensed healthcare practitioners as a reference tool. It does not supersede individual clinical assessment, diagnostic testing, or institutional clinical protocols.